Literature DB >> 12589178

Sympathetic control of the circulation in hypertension: lessons from autonomic disorders.

Italo Biaggioni1.   

Abstract

PURPOSE OF THE REVIEW: Inappropriate sympathetic overactivity is consistently observed in patients with essential hypertension. The present review summarizes the recent advances that have been made in our understanding of the role of the sympathetic nervous system in hypertension. RECENT
FINDINGS: Studies in patients with autonomic disorders underscore the role of the sympathetic nervous system in the long-term maintenance of hypertension. Abnormalities in the afferent limb of the sympathetic nervous system, in the regulation of central neurons where sympathetic outflow originates, and in the modulation of efferent sympathetic function, can all produce autonomic disorders that are associated with hypertension. More subtle dysfunctions in any of these components have been described in essential hypertension and can contribute to its pathogenesis. These include impaired buffering capacity of arterial baroreflexes, increased central sympathetic outflow, and enhanced norepinephrine release (or decrease reuptake) from sympathetic nerve terminals. Whether genetic polymorphisms of adrenoreceptors are associated with essential hypertension is an area of active research.
SUMMARY: Increased sympathetic activity can contribute to sustained hypertension not only because of its hemodynamic effects (increased cardiac output and vascular resistance), but also by altering renal and water handling by the kidney, and by inducing cardiac and vascular remodeling. Antihypertensive agents that directly or indirectly target this sympathetic overactivity may be particularly useful in long-term treatment of essential hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12589178     DOI: 10.1097/00041552-200303000-00008

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  7 in total

1.  Pendrin localizes to the adrenal medulla and modulates catecholamine release.

Authors:  Yoskaly Lazo-Fernandez; Greti Aguilera; Truyen D Pham; Annie Y Park; William H Beierwaltes; Roy L Sutliff; Jill W Verlander; Karel Pacak; Adeboye O Osunkoya; Carla L Ellis; Young Hee Kim; Gregory L Shipley; Brandi M Wynne; Robert S Hoover; Shurjo K Sen; Paul M Plotsky; Susan M Wall
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-07-14       Impact factor: 4.310

Review 2.  Isometric Handgrip as an Adjunct for Blood Pressure Control: a Primer for Clinicians.

Authors:  Cheri L McGowan; David N Proctor; Ian Swaine; Robert D Brook; Elizabeth A Jackson; Phillip D Levy
Journal:  Curr Hypertens Rep       Date:  2017-06       Impact factor: 5.369

3.  The differences in brain stem transcriptional profiling in hypertensive ISIAH and normotensive WAG rats.

Authors:  Larisa A Fedoseeva; Leonid O Klimov; Nikita I Ershov; Vadim M Efimov; Arcady L Markel; Yuriy L Orlov; Olga E Redina
Journal:  BMC Genomics       Date:  2019-05-08       Impact factor: 3.969

4.  Potent and Selective Inhibitors of Long Chain l-2-Hydroxy Acid Oxidase Reduced Blood Pressure in DOCA Salt-Treated Rats.

Authors:  Dinesh A Barawkar; Ashwin Meru; Anish Bandyopadhyay; Abir Banerjee; Anil M Deshpande; Chandrashekhar Athare; Chandrasekhar Koduru; Goraksha Khose; Jayasagar Gundu; Koshu Mahajan; Pradeep Patil; Sachin R Kandalkar; Sanjay Niranjan; Shubhangi Bhosale; Siddhartha De; Sudit Mukhopadhyay; Sumit Chaudhary; Summon Koul; Umesh Singh; Anita Chugh; Venkata P Palle; Kasim A Mookhtiar; Joseph Vacca; Prasun K Chakravarty; Ravi P Nargund; Samuel D Wright; Sophie Roy; Michael P Graziano; Sheo B Singh; Doris Cully; Tian-Quan Cai
Journal:  ACS Med Chem Lett       Date:  2011-10-07       Impact factor: 4.345

Review 5.  Environmental origins of hypertension: phylogeny, ontogeny and epigenetics.

Authors:  Melvin Khee-Shing Leow
Journal:  Hypertens Res       Date:  2015-02-19       Impact factor: 3.872

6.  Chronic ethanol attenuates centrally-mediated hypotension elicited via alpha(2)-adrenergic, but not I(1)-imidazoline, receptor activation in female rats.

Authors:  Mahmoud M El-Mas; Abdel A Abdel-Rahman
Journal:  Life Sci       Date:  2008-11-17       Impact factor: 5.037

7.  The Valsalva maneuver: screening for drug-induced baroreflex dysfunction.

Authors:  Christoph Schroeder; Karsten Heusser; Jens Tank; André Diedrich; Friedrich C Luft; Jens Jordan
Journal:  Clin Auton Res       Date:  2008-11-15       Impact factor: 4.435

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.